FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292458168> ?p ?o ?g. }

• W4292458168 endingPage "5081" @default.
• W4292458168 startingPage "5081" @default.
• W4292458168 abstract "Aim. To determine the possible impact of anxiety and depression disorders on the adherence of patients with atrial fibrillation (AF) to anticoagulant the rapy. Material and methods . The study included outpatients with AF of any type. After signing the informed consent, patients filled out questionnaires and scales that determined the level of anxiety and personal predisposition (MMAS-8, MMAS-4, SF-36, SHAI, STAI, HADS, NEO-FFI). Results . A total of 117 outpatients treated for AF were included. The mean age of patients was 74±5 years (men, 38%). Based on MMAS-4 and MMAS-8 results, adherent and non-adherent cohorts of patients were formed. Low adherence group had significantly higher situational anxiety according to STAI (45,9±9,9 vs 41,1±10,7, p=0,045) and depression according to HADS (7,9±3,6 vs 5,9±3,5, p=0,018). SF 36 showed that non-adherent patients had a lower general health (41,6±12,9 vs 52,2±20,0, p=0,01). Five-factor model revealed an association between low compliance and low extraversion (21,3±6,6 vs 26,4±7,2, p=0,002). Pharmacokinetic data on blood concentrations of anticoagulants or its metabolites at the second visit were available in 76 (67%) patients. Assessment of pharmacokinetic and compliance data revealed a moderate direct correlation (Matthews correlation coefficient (MCC), 0,345) and a weak direct correlation with the MMAS-8 (MCC, 0,177). The difference in MMAS-4 and MMAS-8 scores between high and low pharmacokinetic adherence groups was significant on both scales (p=0,011 and 0,015, respectively). Conclusion. The rationale for widespread introduction of standardized questionnaires and scales (MMAS 4, MMAS 8, STAI, HADS, SF 36, Big 5) was shown in order to early identify patients with low adherence to treatment. The results highlight the need for further study of the contribution of psychiatric disorders to low compliance to anticoagulant therapy." @default.
• W4292458168 created "2022-08-20" @default.
• W4292458168 creator A5017033212 @default.
• W4292458168 creator A5019827876 @default.
• W4292458168 creator A5025374944 @default.
• W4292458168 creator A5032164583 @default.
• W4292458168 creator A5033628913 @default.
• W4292458168 creator A5052597044 @default.
• W4292458168 creator A5054529538 @default.
• W4292458168 creator A5083091177 @default.
• W4292458168 creator A5083704479 @default.
• W4292458168 date "2022-08-09" @default.
• W4292458168 modified "2023-09-24" @default.
• W4292458168 title "Impact of anxiety and depression disorders on adherence to anticoagulant therapy among patients with atrial fibrillation" @default.
• W4292458168 cites W1975227812 @default.
• W4292458168 cites W2003172080 @default.
• W4292458168 cites W2031756259 @default.
• W4292458168 cites W2068429835 @default.
• W4292458168 cites W2113750014 @default.
• W4292458168 cites W2114055259 @default.
• W4292458168 cites W2171369299 @default.
• W4292458168 cites W2563665632 @default.
• W4292458168 cites W2797973998 @default.
• W4292458168 cites W2973368828 @default.
• W4292458168 cites W3115510175 @default.
• W4292458168 doi "https://doi.org/10.15829/1560-4071-2022-5081" @default.
• W4292458168 hasPublicationYear "2022" @default.
• W4292458168 type Work @default.
• W4292458168 citedByCount "0" @default.
• W4292458168 crossrefType "journal-article" @default.
• W4292458168 hasAuthorship W4292458168A5017033212 @default.
• W4292458168 hasAuthorship W4292458168A5019827876 @default.
• W4292458168 hasAuthorship W4292458168A5025374944 @default.
• W4292458168 hasAuthorship W4292458168A5032164583 @default.
• W4292458168 hasAuthorship W4292458168A5033628913 @default.
• W4292458168 hasAuthorship W4292458168A5052597044 @default.
• W4292458168 hasAuthorship W4292458168A5054529538 @default.
• W4292458168 hasAuthorship W4292458168A5083091177 @default.
• W4292458168 hasAuthorship W4292458168A5083704479 @default.
• W4292458168 hasBestOaLocation W42924581681 @default.
• W4292458168 hasConcept C118552586 @default.
• W4292458168 hasConcept C126322002 @default.
• W4292458168 hasConcept C139719470 @default.
• W4292458168 hasConcept C162324750 @default.
• W4292458168 hasConcept C203440823 @default.
• W4292458168 hasConcept C2776867660 @default.
• W4292458168 hasConcept C2779161974 @default.
• W4292458168 hasConcept C558461103 @default.
• W4292458168 hasConcept C71924100 @default.
• W4292458168 hasConceptScore W4292458168C118552586 @default.
• W4292458168 hasConceptScore W4292458168C126322002 @default.
• W4292458168 hasConceptScore W4292458168C139719470 @default.
• W4292458168 hasConceptScore W4292458168C162324750 @default.
• W4292458168 hasConceptScore W4292458168C203440823 @default.
• W4292458168 hasConceptScore W4292458168C2776867660 @default.
• W4292458168 hasConceptScore W4292458168C2779161974 @default.
• W4292458168 hasConceptScore W4292458168C558461103 @default.
• W4292458168 hasConceptScore W4292458168C71924100 @default.
• W4292458168 hasIssue "7" @default.
• W4292458168 hasLocation W42924581681 @default.
• W4292458168 hasLocation W42924581682 @default.
• W4292458168 hasOpenAccess W4292458168 @default.
• W4292458168 hasPrimaryLocation W42924581681 @default.
• W4292458168 hasRelatedWork W1967841144 @default.
• W4292458168 hasRelatedWork W2018480046 @default.
• W4292458168 hasRelatedWork W2064495796 @default.
• W4292458168 hasRelatedWork W2319489406 @default.
• W4292458168 hasRelatedWork W2333279585 @default.
• W4292458168 hasRelatedWork W2603808924 @default.
• W4292458168 hasRelatedWork W2763816051 @default.
• W4292458168 hasRelatedWork W2793053827 @default.
• W4292458168 hasRelatedWork W2889073610 @default.
• W4292458168 hasRelatedWork W3132289493 @default.
• W4292458168 hasVolume "27" @default.
• W4292458168 isParatext "false" @default.
• W4292458168 isRetracted "false" @default.
• W4292458168 workType "article" @default.